Showing 1 to 10 of 19 Clinical Trials
|
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
|---|---|---|---|
|
A Phase III Trial of Stereotactic Radiosurgery Compared With Whole Brain Radiotherapy (WBRT) for 5-15 Brain Metastases
CE.7 NCT03550391  Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Brain |
Dr. David Roberge Mom Phat 514-890-8000 poste 11171 |
|
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
NRG-BN003 NCT03180268 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Brain |
Dr. Bassam Abdulkarim Ginette Ricard 514-934-1934 poste 43186 |
|
A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine With Lomustine Compared to Lomustine Alone in Patients With AA That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy
Orbus OT-15-0011 NCT02796261 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
HOPITAL NEUROLOGIQUE DE MONTREAL
|
Brain |
Dr. Kevin Petrecca Gabriele Riva 514-398-6907 |
|
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
BN001 NCT02179086 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
L'HOTEL-DIEU DE QUEBEC ET CRCEO
|
Brain |
Dr. Nathalie Lessard Josée Allard 418-525-4444 poste 16730 |
|
A Phase II Study in Relapsing Glioblastoma of Intraarterial Concurrent Chemoradiation Therapy Using IA Carboplatin
2018-2452 NCT03672721 Recruiting
|
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT
|
Brain |
Dr. David Fortin Marie-Andrée Roy 819-346-1110 poste 13895 |
|
A Phase III Trial of Stereotactic Radiosurgery Compared With Whole Brain Radiotherapy (WBRT) for 5-15 Brain Metastases
CE.7 NCT03550391 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Brain |
Dr. Valérie Panet-Raymond Evelyn Ortega 514-934-1934 poste 48354 |
|
A Phase III Trial of Stereotactic Radiosurgery Compared With Whole Brain Radiotherapy (WBRT) for 5-15 Brain Metastases
CE.7 NCT03550391 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
L'HOTEL-DIEU DE QUEBEC ET CRCEO
|
Brain |
Dr. Jean Archambault Josée Allard 418-525-4444 poste 16730 |
|
A Phase III Trial of Stereotactic Radiosurgery Compared With Whole Brain Radiotherapy (WBRT) for 5-15 Brain Metastases
CE.7 NCT03550391 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
Brain |
Dr. Thierry Muanza Latha Raja 514-340-8222 poste 27715 |
|
A Randomized Phase III Trial of Pre-Operative Compared to Post-Operative Stereotactic Radiosurgery in Patients With Resectable Brain Metastases
NRG-BN012 NCT05438212 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Brain |
Dr. Christina Tsien Tatiana Carvalho 514-934-1934 poste 43698 |
|
A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)
COG-ACNS1831 NCT03871257 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
HOPITAL DE MONTREAL POUR ENFANTS
|
Brain |
Dr. Geneviève Legault Stephanie Badour 514-412-4400 poste 23807 |
Groupe d'étude en oncologie du Québec